These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7070006)

  • 21. Consumption coagulopathy in congenital heart-disease.
    Ihenacho HN; Fletcher DJ; Breeze GR; Stuart J
    Lancet; 1973 Feb; 1(7797):231-4. PubMed ID: 4119378
    [No Abstract]   [Full Text] [Related]  

  • 22. Improvement in hemostasis following phlebotomy in cyanotic patients with heart disease.
    Wedemeyer AL; Lewis JH
    J Pediatr; 1973 Jul; 83(1):46-50. PubMed ID: 4768936
    [No Abstract]   [Full Text] [Related]  

  • 23. The Coagulative Profile of Cyanotic Children Undergoing Cardiac Surgery: The Role of Whole Blood Preoperative Thromboelastometry on Postoperative Transfusion Requirement.
    Vida VL; Spiezia L; Bortolussi G; Marchetti ME; Campello E; Pittarello D; Gregori D; Stellin G; Simioni P
    Artif Organs; 2016 Jul; 40(7):698-705. PubMed ID: 26611664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the coagulation and anticoagulation system of the blood in patients with congenital defects of the heart of the cyanotic type].
    Iufit SE; Zargarli FI; Tolpekin VE
    Kardiologiia; 1967 Mar; 7(3):136-7. PubMed ID: 5604602
    [No Abstract]   [Full Text] [Related]  

  • 25. Preoperative and postoperative platelet function in cyanotic congenital heart disease.
    Ekert H; Sheers M
    J Thorac Cardiovasc Surg; 1974 Feb; 67(2):184-90. PubMed ID: 4810991
    [No Abstract]   [Full Text] [Related]  

  • 26. [The morphological picture of the blood and blood cell indices in children with congenital cyanotic heart disease].
    Wróblewska-Kaluzewska M
    Pediatr Pol; 1970 Jun; 45(6):697-701. PubMed ID: 5488831
    [No Abstract]   [Full Text] [Related]  

  • 27. [Alteration of hemostasis during open heart surgery with E. C. C. (author's transl)].
    Watel A; Foreau C; Vannier V; Pol A; Cosson A; Soots G
    Anesth Analg (Paris); 1979; 36(5-6):193-8. PubMed ID: 496041
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pathogenesis, prophylaxis and therapy of hemostatic disorders in congenital cardiopathies].
    Perlick E; Ursinus K; Ursinus W; Hofmann G
    Z Gesamte Inn Med; 1971 Sep; 26(17):545-51. PubMed ID: 5125158
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hamostasiological changes induced by platelet-aggregation-inhibitors, tested in children with congenital heart disease (in vitro and in vitro examinations) (author's transl)].
    Schmidt B; Sutor H; Lorenz H
    Klin Padiatr; 1976 Sep; 188(5):424-9. PubMed ID: 987505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Incidence of anaemia in congenital heart diseases (author's transl)].
    Drossos C; Thanapoulos B; Papadimitrou T; Milingos M; Papadimitrou A; Kostantelloy E; Ikkos D
    Pediatr Med Chir; 1981; 3(4):309-12. PubMed ID: 7343922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shortened platelet survival in cyanotic heart disease.
    Waldman JD; Czapek EE; Paul MH; Schwartz AD; Levin DL; Schindler S
    J Pediatr; 1975 Jul; 87(1):77-9. PubMed ID: 1151551
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease.
    Rosenthal A; Nathan DG; Marty AT; Button LN; Miettinen OS; Nadas AS
    Circulation; 1970 Aug; 42(2):297-308. PubMed ID: 5431926
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet adhesiveness in cyanotic cogenital heart disease.
    Goldschmidt B; Kun E
    Acta Paediatr Acad Sci Hung; 1973; 14(2):99-103. PubMed ID: 4763565
    [No Abstract]   [Full Text] [Related]  

  • 34. [Heparinization during transvenous cardiac catheterizations in young infants (author's transl)].
    Schreiber R; Schumacher G; Bühlmeyer K
    Klin Padiatr; 1979 May; 191(3):280-6. PubMed ID: 572445
    [No Abstract]   [Full Text] [Related]  

  • 35. Chorea, polycythaemis, and cyanotic heart disease.
    Edwards PD; Prosser R; Wells CE
    J Neurol Neurosurg Psychiatry; 1975 Aug; 38(8):729-39. PubMed ID: 1185193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinopathy and papilledema in cyanotic congenital heart disease.
    Petersen RA; Rosenthal A
    Pediatrics; 1972 Feb; 49(2):243-9. PubMed ID: 5059530
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hemostatic changes in congenital heart diseases].
    Hrodek O; Padovcová H; Vorísková M
    Cesk Pediatr; 1972 Feb; 27(2):59-63. PubMed ID: 5010878
    [No Abstract]   [Full Text] [Related]  

  • 38. [Neurological complications in children with congenital cyanotic heart disease (author's transl)].
    Schmaltz AA; Siegler P; Nolte R; Apitz J
    Monatsschr Kinderheilkd; 1980 Sep; 128(9):606-10. PubMed ID: 6107846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of platelet count in pediatric patients with congenital cyanotic heart disease: Role of immature platelet fraction.
    Matter RM; Ragab IA; Roushdy AM; Ahmed AG; Aly HH; Ismail EA
    Congenit Heart Dis; 2018 Jan; 13(1):118-123. PubMed ID: 28880458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematological profile in children with congenital heart disease.
    Hooja V; Sanyal SK; Agarwal KN; Dasgupta BN; Ghosh S
    Indian J Med Res; 1971 Jul; 59(7):1054-61. PubMed ID: 5161550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.